EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.99.1 | arachidonic acid + AH2 + 2 O2 |
- |
Mus musculus |
15(R)-hydroxy-eicosatetraenoic acid + A + H2O |
product of aspirin treated enzyme |
? |
1.14.99.1 | arachidonic acid + AH2 + 2 O2 |
- |
Homo sapiens |
15(R)-hydroxy-eicosatetraenoic acid + A + H2O |
product of aspirin acetylated enzyme or S516M mutant |
? |
1.14.99.1 | arachidonic acid + AH2 + 2 O2 |
- |
Ovis aries |
15-hydroperoxy-9alpha,11alpha-peroxidoprosta-5,13-dienoic acid + A + H2O |
- |
? |
1.14.99.1 | arachidonic acid + AH2 + 2 O2 |
activity assay |
Homo sapiens |
6-keto-prostaglandin F1alpha + A + H2O |
- |
? |
1.14.99.1 | linoleic acid + AH2 + O2 |
- |
Homo sapiens |
9-hydroxyoctadecadienoic acid + 13-hydroxyoctadecadienoic acid + ? |
- |
? |
1.14.99.1 | linoleic acid + AH2 + O2 |
- |
Ovis aries |
9-hydroxyoctadecadienoic acid + 13-hydroxyoctadecadienoic acid + ? |
- |
? |
1.14.99.1 | alpha-linolenic acid + reduced acceptor + O2 |
- |
Ovis aries |
? |
- |
r |
1.14.99.1 | alpha-linolenic acid + reduced acceptor + O2 |
- |
Salvelinus fontinalis |
? |
- |
r |
1.14.99.1 | arachidonic acid + 3,4-methylenedioxyamphetamine |
postulated bioactivation to a neurodegenerative free radical intermediate that can initiate the formation of reactive oxygen species |
Mus musculus |
? |
- |
? |
1.14.99.1 | arachidonic acid + 3,4-methylenedioxymethamphetamine |
postulated bioactivation to a neurodegenerative free radical intermediate that can initiate the formation of reactive oxygen species |
Mus musculus |
? |
- |
? |